Close X
my esmo
 
Username: Password:
Remember me!


Forgot your Password? Create an account

Use of the ESMO services is subject to the Terms & Conditions and constitutes your agreement to abide by these.

Close X
my esmo
 
Username: Password:
Remember me!


Forgot your Password? Create an account

Use of the ESMO services is subject to the Terms & Conditions and constitutes your agreement to abide by these.

ESMO Clinical Practice Guidelines

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine. Each CPG includes information on the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up.

ESMO is pleased to release the latest enhanced and revised set of guidelines designed to help oncologists deliver an appropriate quality of care to their patients.

ESMO Consensus Conferences ESMO Clinical Practice Guidelines, May 2010: Vol. 21, Supplement No. 5

Editorial

New in 2011!
Fourteen years of evolution of ESMO Guidelines:
from the minimum recommendations to the Consensus Conference-derived guidelines
N. Pavlidis, R. Stahel, H. Hansen, and A. Cervantes FULL TEXT PDF

To top

Breast cancer

New in 2011!
Primary breast cancer
S. Aebi, T. Davidson, G. Gruber, F. Cardoso FULL TEXT PDF
New in 2011!
Locally recurrent or metastatic breast cancer
F. Cardoso, L. Fallowfield, A. Costa, M. Castiglione, E. Senkus FULL TEXT PDF
New in 2011!
BRCA in breast cancer
J. Balmana, O. Diez, I.T. Rubio, F. Cardoso FULL TEXT PDF

To top

Gynecologic tumors

Newly and relapsed epithelial
ovarian carcinoma
N. Colombo, M. Peiretti, G. Parma,
M. Lapresa, R. Mancari, S. Carinelli,
C. Sessa, M. Castiglione
FULL TEXT PDF
Non-epithelial ovarian cancer N. Reed, D. Millan, R. Verheijen,
M. Castiglione
FULL TEXT PDF
Cervical cancer C. Haie-Meder, P. Morice, M. Castiglione FULL TEXT PDF
New in 2011!
Endometrial cancer
N. Colombo, E. Preti, F. Landoni,
S. Carinelli, A. Colombo, C. Marini, C. Sessa
FULL TEXT PDF

To top

Gastrointestinal tumors

Esophageal cancer M. Stahl, W. Budach, H.-J. Meyer, A. Cervantes FULL TEXT PDF
Gastric cancer A. Okines, M. Verheij, W. Allum,
D. Cunningham, A. Cervantes
FULL TEXT PDF
Pancreatic cancer C. Cascinu. M. Falconi, V. Valentini,
S. Jelic
FULL TEXT PDF
Hepatocellular carcinoma S. Jelic, G. C. Sotiropoulos FULL TEXT PDF
New in 2011!
Biliary cancer
F. Eckel, T. Brunner, S. Jelic FULL TEXT PDF
Primary colon cancer R. Labianca, B. Nordlinger, G. D. Beretta,
A. Brouquet, A. Cervantes
FULL TEXT PDF
Familial colorectal cancer risk J. Balmaña, A. Castella, A. Cervantes FULL TEXT PDF
Rectal cancer B. Glimelius, L. Påhlman, A. Cervantes FULL TEXT PDF
Anal cancer R. Glynne-Jones, J. M. A. Northover, A. Cervantes FULL TEXT PDF
Advanced colorectal cancer E. Van Cutsem, B. Nordliner, A. Cervantes FULL TEXT PDF
Gastrointestinal stromal tumours P. G. Casali, J.-Y- Blay FULL TEXT PDF

To top

Lung cancer

Early-stage and locally
advanced (non-metastatic)
non small cell lung cancer
L. Crinò, W. Weder, J. van Meerbeeck,
E. Felip
FULL TEXT PDF
Metastatic non small cell lung cancer G. D’Addario, M. Früh, M. Reck,
P. Baumann, W. Klepetko, E. Felip
FULL TEXT PDF
Small-cell lung cancer M. Sørensen, M. Pijls-Johannesma. E. Felip FULL TEXT PDF
Malignant pleural mesothelioma R. A. Stahel, W. Weder, Y. Lievens, E. Felip FULL TEXT PDF

To top

Urogenital tumors

Prostate cancer A. Horwich, C. Parker, C. Bangma, V. Kataja FULL TEXT PDF
New in 2011!
Bladder cancer
J. Bellmunt, A. Orsola, T. Wiegel,
M. Guix, M. De Santis, V. Kataja
FULL TEXT PDF
Renal cell cancer B. Escudier, V. Kataja FULL TEXT PDF
Testicular seminoma H.-J. Schmoll, K. Jordan, R. Huddart,
M. P. Laguna, A. Horwich, K. Fizazi and V. Kataja
FULL TEXT PDF
Testicular non-seminoma H.-J. Schmoll, K. Jordan, R. Huddart,
M. P. Laguna, A. Horwich, K. Fizazi and V. Kataja
FULL TEXT PDF

To top

Hematologic malignancies

Multiple myeloma J.-L. Harousseau and M. Dreyling FULL TEXT PDF
Acute myeloblastic leukemia
in adult patients
M. Fey and M. Dreyling FULL TEXT PDF
New in 2011!
Chronic lymphocytic leukemia
B. Eichhorst, M. Dreyling, T. Robak. E.Montserrat, M. Hallek FULL TEXT PDF
Chronic myeloid leukemia M. Baccarani and M. Dreyling FULL TEXT PDF
New in 2011!
Hodgkin's lymphoma
D.A. Eichenauer, A. Engert, M. Dreyling FULL TEXT PDF
Diffuse large B-cell
non-Hodgkin's lymphoma
H. Tilly and M. Dreyling FULL TEXT PDF
Gastric marginal zone lymphoma
of MALT type
E. Zucca and M. Dreyling FULL TEXT PDF
Primary cutaneous lymphoma R. Willemze and M. Dreyling FULL TEXT PDF
New in 2011!
Newly diagnosed and relapsed
follicular lymphoma
M. Dreyling, M. Ghielmini, R. Marcus, G. Salles, U. Vitolo FULL TEXT PDF

To top

Head and neck tumors

Squamous cell carcinoma of
the head and neck
V. Grégoire, J.-L. Lefebvre, L. Licitra,
E. Felip
FULL TEXT PDF
Nasopharyngeal cancer A. T. C. Chan, V. Greégroire, J.-L. Lefebvre,
L. Licitra, E. Felip
FULL TEXT PDF

To top

CNS

High-grade malignant glioma R. Stupp,J.-C. Tonn, M. Brada,G. Pentheroudakis FULL TEXT PDF

To top

Sarcomas and melanomas

Melanoma R. Dummer, A. Hauschild, M. Guggenheim,
L. Jost, G. Pentheroudakis
FULL TEXT PDF
Soft tissue sarcomas P.G. Casali, J.-Y. Blay FULL TEXT PDF
Bone sarcomas P.C.W. Hogendoorn FULL TEXT PDF

To top

Neuroendocrine tumors

Thyroid cancer F. Pacini, M. G. Castagna, L. Brilli
and G. Pentheroudakis
FULL TEXT PDF
Neuroendocrine bronchial and
thymic tumors
K. Öberg, P. Hellman, D. Kwekkeboom,
S. Jelic
FULL TEXT PDF
Neuroendocrine gastroenteropancreatic
tumors
K. Öberg, G. Åkerström, G. Rindi,
S. Jelic
FULL TEXT PDF
New in 2011!
Cancers of unknown primary site
K. Fizazi, F. A. Greco, N. Pavlidis, G. Pentheroudakis FULL TEXT PDF

To top

Supportive care

Guideline update for MASCC & ESMO
in the prevention of chemotherapy
and radiotherapy-induced nausea
and vomiting
F. Roila, J. Herrstedt, M. Aapro,
R. J. Gralla, L.H. Einhorn, E. Ballatori,
E. Bria, R.A. Clark-Snow,
B. T. Espersen, P. Feyer, S.M. Grunberg,
P.J. Hesketh, K. Jordan, M.G. Kris,
E. Maranzano, A. Molassiotis, G. Morrow,
I. Olver, B.L. Rapoport, C. Rittenberg,
M. Saito, M. Tonato, D. Warr
FULL TEXT PDF
Erythropoiesis-stimulating agents
in the treatment of anaemia
in cancer patients
D. Schrijvers, H. De Samblanx, F. Roila FULL TEXT PDF
Hematopoietic growth factors J. Crawford, C. Caserta, F. Roila FULL TEXT PDF
Management of febrile neutropenia J. de Naurois, I. Novitzky-Basso, M. J. Gill,
F. Marti Marti, M. H. Cullen, F. Roila
FULL TEXT PDF
New in 2011!
Management of cancer pain
C. I. Ripamonti, E. Bandieri, F. Roila FULL TEXT PDF
New in 2011!
Management of oral and
gastrointestinal mucositis
D. E. Peterson, R.-J. Bensadoun
and F. Roila
FULL TEXT PDF
Cancer, fertility and pregnancy G. Pentheroudakis, R. Orecchia, H. J. Hoekstra,
N. Pavlidis
FULL TEXT PDF
New in 2011!
Management of venous
thromboembolism (VTE) in cancer patients
M. Mandalà, A. Falanga
and F. Roila
FULL TEXT PDF
Cardiotoxicity of chemotherapeutic
agents and radiotherapy-related
heart disease
D. Bovelli, G. Plataniotis, F. Roila FULL TEXT PDF

To top

Acknowledgements

The ESMO Guidelines Working Group acknowledges and thanks the people who have acted as reviewers for these ESMO Clinical Practice Guidelines

Click here to see the list

Guidelines Working Group Members

Click here to see the list

Disclosures

The members of the Guidelines Working Group have made the following disclosures

Click here to see the list

Clinical Practice Guidelines are not designed to replace extensive clinical practice guidelines or review articles, but rather to describe common standards of care.

The ESMO CPG are updated annually by the ESMO Guidelines Working Group, who manages and supervises them, while the ESMO Faculty members perform reviews and provide further expert opinion.

Clinical guidelines are important for the development of oncology as a specialty and serve to achieve many important goals:

  • reach and maintain a high common standard of care in medical practice for cancer patients and help clinicians to offer the best care
  • disseminate knowledge by supporting the translation into many languages
  • support negotiations with politicians, administrators and insurance companies regarding what level of care should be made available
  • help patients to find information on the therapies they are undergoing